Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Publikationen

Publications

Literatur

Onlinemodule LEXIA

Modules en ligne LEXIA

Bücher

Livres

Buchreihen

Collections

Datenbanken

recht.ch

Studienliteratur

Littérature pour les études

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Unsere Funktionen

Nos fonctions

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Gesamtkatalog

Catalogue complet

Nutritional Neuroscience

From Bench to Bedside

While people with autism and other intellectual and developmental disabilities receive extensive services for their behavioral health needs, many continue to struggle and lack a positive quality of life. The primary reason for referral for professional mental health care is most often the occurrence of aggression and other externalizing behaviors. Aggressive Behavior of People with Autism and other Intellectual and Developmental Disability explores the primary factors influencing the occurrence of aggression in this population are reviewed, and offers practical suggestions for improving outcomes. Topics covered include understanding effects of neurodevelopmental disorders, multiple factors frequently impacting risk for aggression, common medical and neurological influences, and the effects of trauma. This book will also introduce a new model for integrating multiple influences into a contextual functional behavior assessment.

Aggressive Behavior of People with Autism and other Intellectual and Developmental Disability

Dance in Dialogue

A series of conversations with researchers and practitioners that explores the critical dynamics of silence within choreography, performance and composition.

In Conversation

Dance and Silence

The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity is a critically acclaimed account detailing the groundbreaking discovery of the hormone GLP-1, narrated by the award-winning scientist Professor Jens Juul Holst, along with co-authors Professor Sten Madsbad, Professor Jens Meldgaard Bruun, and Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation. GLP-1 is the hormone found in weight loss medications and diabetes treatments such as Ozempic and Wegovy. The discovery of GLP-1 has significantly transformed treatment options for individuals with type 2 diabetes and obesity, offering benefits that include improved blood glucose regulation and substantial weight loss, while also lowering the risk of related complications. Professor Jens Juul Holst, MD, DMSc, is among the world's leading diabetes researchers, having pioneered the discovery of GLP-1 in the 1980s. In this book, we follow the historical research journey that led to the identification of this hormone, which now signifies a paradigm shift in the management of diabetes and obesity. "The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity" narrates the rising rates of obesity and diabetes, underscoring a critical public health issue, even in light of considerable progress in treatment alternatives. While traditional approaches, such as low-calorie diets, have shown potential for short-term weight loss, maintaining that loss has proven difficult. Efforts to achieve better blood sugar control have not consistently translated into reduced complications or improved patient outcomes, as demonstrated by extensive international studies. However, the introduction of new diabetes medications, particularly those based on glucagon-like peptide-1 (GLP-1), such as liraglutide and semaglutide, has marked a significant breakthrough. These medications not only improve blood sugar levels but also promote substantial weight loss and reduce cardiovascular complications, offering hope for better management of obesity and diabetes. Despite these promising results, challenges remain regarding accessibility and affordability of these treatments, raising important societal questions about who should receive them and how they should be funded. The author's involvement in the discovery and development of GLP-1 provides a unique perspective on the historical and physiological context of these advancements, making this book a valuable resource for understanding the complexities of metabolic diseases and the evolution of treatment options.

A Historical Journey in the Treatment of Diabetes and Obesity

The Story of GLP-1

Medicinal Plants in Parkinson's Therapy

A transformative guide to rethinking our approach to goals, creativity and life itself from a neuroscientist and entrepreneur'A compelling new take on a timeless concern' - CAL NEWPORT'I loved this profound, practical and generous book' - OLIVER BURKEMAN'Perfect for anyone seeking more freedom in how they design their life' - ALI ABDAAL'One of the best productivity books that I've read' - RYDER CARROLL'This book will change the way you design your goals and live your life' - NIR EYALWe're told productivity is all about single-minded focus, hard grind and big goals. Deviating from the linear path means failure. The problem: it's not true. In this transformative book, neuroscientist and entrepreneur Anne-Laure Le Cunff reveals the easier, proven method to achieve our ambitions: an experimental mindset. Ditching out-dated notions of chasing success, she demonstrates the joyful power of 'tiny experiments' in which goals are discovered, pursued and adapted on your own terms. Rooted in science and real-world success stories, Tiny Experiments is packed with tools to help you break free from limiting beliefs, harness the power of imperfection and apply your curiosity - to create a meaningful, productive life in an ever-changing world.

How to Live Freely in a Goal-Obsessed World

Tiny Experiments

Handbook of Clinical Neurology

The evolution of neuroimmunotherapies with the concurrent progress in autoimmune neurology will introduce the book, followed by an update on "non-targeted" therapies highlighting the value of immunosuppressants, plasmapheresis, IVIg or hematopoietic bone marrow transplantation and their mode of action in autoimmune neurology. The new agents in each of these categories, along with biomarkers for therapeutic monitoring and the application of reliable scales in assessing response, will be covered. Chapters will discuss how neuroimmunotherapies work when key molecules and pathways associated with CNS or PNS tissue damage are targeted or inhibited. The volume will describe the approved agents targeting: 1) T-cell intracellular signaling pathways and molecules associated with antigen presentation; 2) B cells, B-cell trophic factors, and autoantibodies; 3) Fc receptor modulation; 4) complement; and 5) cytokines, cell adhesion and transmigration molecules. Didactic schemes and illustrations on how these drugs work in autoimmune neurological diseases will be provided in each chapter. The second part of the book will discuss the latest therapeutics for each major autoimmune neurological disease, aimed to provide a reliable, comprehensive and up-to-date source of information useful for clinical practice and education. Didactic and practical algorithms, a step-by step approach on how best to apply the most suitable therapies for a given state of the disease or proceed to escalation therapies will be provided. Treatment controversies and uncertainties will be authoritatively emphasized by scholars in each field. A chapter addressing potential immunotherapeutic approaches, now on the pipeline or on early trials, as future means of treating some neurodegenerative diseases will be included. Another chapter will cover the new and popular-although controversial -concept of treating autoimmune pain. The book discusses practical therapies with¿traditional immunosuppressants, steroids and IVIg. It describes targeted therapies with monoclonal antibodies or fusion proteins against B cells , T cells, complement, and FcRn, discussing what happens when key factors related to neurological autoimmunity are inhibited. The book provides a "how- to- do" approach for each of the major autoimmune diseases with algorithms and escalation therapies. Dedicated chapters will cover current therapies on encephalitis, NMOSD, Multiple sclerosis , autoimmune neuropathies, myopathies, neuromuscular junction disorders and neuroexcitability disorders like stiff person syndrome. The book is aimed for practitioners and academicians as a reliable and comprehensive source for applying neuroimmunotherapies and understanding their mechanisms.

Immunotherapies for Neurologic Diseases: Volume 214

Brainstem

A Modern Atlas for Implantable Devices of the Spine, Brain, and Nerve: For Pain, Movement Disorders, and Nerve Dysfunction is an essential resource for healthcare professionals and researchers working in neuromodulation. This groundbreaking text focuses on the latest advancements in implantable technologies, exploring innovative techniques, frequencies, and neural targets that have revolutionized patient care. Covering a diverse range of conditions related to pain, movement disorders, and nerve dysfunction, the atlas provides a detailed overview of spinal, brain, and peripheral nerve procedures. It combines anatomical insights with clinical best practices to help professionals achieve enhanced outcomes in complex medical scenarios. In addition to introducing cutting-edge devices, the book delves into procedures like spinal cord stimulation and dorsal root ganglion modulation, offering a roadmap for navigating intricate anatomical and procedural landscapes. The atlas includes valuable sections on sacral nerve modulation and peripheral nerve stimulation, ensuring comprehensive coverage of neuromodulation's expanding possibilities. By bridging theoretical knowledge with practical application, this resource equips practitioners with the tools needed to address diverse patient challenges effectively.

For Pain, Movement Disorders, and Nerve Dysfunction

A Modern Atlas for Implantable Devices of the Spine, Brain, and Nerve

From Concept to Validated Application

Paraprobiotics, Postbiotics and Psychobiotics in Foods

The Neurological and Immunological Basis of Itch and Dermatological Disorders covers the latest research on neurological itch signaling pathway from the skin to the brain. With a multidisciplinary approach, this book will cover the mechanisms underlying the sensation of itch from the fields of neuroscience, immunology, genetics, and dermatology as they have intersected in the study of one somatosensory system. The purpose of this comprehensive reference is the summarize the revelatory discoveries in the field of itch and provide a comprehensive overview of what is known about this remarkable sensation and how various pathologies contribute to chronic pruritis.

The Neurological and Immunological Basis of Itch and Dermatological Disorders

This book reviews the potential of natural products in the treatment and management of neurodegenerative disorders. The introductory chapter provides fundamental insights into neurodegenerative disorders. Subsequently, the book covers the therapeutic potential of polyphenols and other agents for Amyotrophic Lateral Sclerosis, the application of natural ingredients for Friedreich ataxia, and the combined effects of natural ingredients in addressing Huntington's disease. The book also explores conventional therapeutic regimens for Lewy body disease and examines the synergistic effects of both natural and synthetic agents. Furthermore, the chapters discuss the utilization of natural extracts in the management of spinal muscular atrophy while examining broader synthetic management approaches. The second section of the book explores nanodelivery systems for managing neurodegenerative disorders. It discusses synergistic treatment approaches, followed by an analysis of advanced techniques such as electron spinning and electron spraying and their application in neurodegenerative disorders. The book also reviews the therapeutic potential of flavonoids in managing neurodegenerative disorders. Towards the end, the book also examines the ethical framework of natural remedies used in the treatment of neurodegenerative disorders. This book is intended for neuroscientists and researchers in the fields of neurology, pharmacology, and nanotechnology. Seasonal blurb This book explores the potential of natural products in the treatment and management of neurodegenerative disorders. It reviews the role of polyphenols for Amyotrophic Lateral Sclerosis, natural ingredients for Friedreich ataxia, and Huntington's disease. The book also examines conventional treatments for Lewy body disease and spinal muscular atrophy and the synergy of natural and synthetic agents. The book presents nanodelivery systems, synergistic treatments, and reviews the ethical framework for the utilization of natural remedies in treating neurodegenerative disorders. This book is a valuable resource for neuroscientists and researchers in neurology, pharmacology, and nanotechnology. Short blurb This book explores the potential of natural products and nanodelivery systems in the treatment and management of neurodegenerative disorders. It also reviews the ethical framework for the utilization of natural remedies in treating neurodegenerative disorders. It is a valuable source for researchers in neurology, pharmacology, and nanotechnology.

Therapeutic Potential of Natural Products in Neurodegenerative Disorders

Psychophysics and Experimental Phenomenology of Pattern Cognition

Nutritional Neuroscience

Weitere Titel zum Thema